Literature DB >> 23376608

Apigenin induces c-Myc-mediated apoptosis in FRO anaplastic thyroid carcinoma cells.

Si Hyoung Kim1, Jun Goo Kang, Chul Sik Kim, Sung-Hee Ihm, Moon Gi Choi, Hyung Joon Yoo, Seong Jin Lee.   

Abstract

Apigenin promotes apoptosis in cancer cells. We studied the effect of apigenin on cell survival and c-Myc expression in FRO anaplastic thyroid carcinoma (ATC) cells. Apigenin caused apoptosis via the elevation of c-Myc levels in conjunction with the phosphorylation of p38 and p53. In the c-Myc siRNA-transfected and apigenin-treated cells, compared with the apigenin-treated control cells, apoptosis and phosphorylation of p38 and p53 were ameliorated. In the presence of apigenin, diminution of p38 and p53 did not affect cell survival although apigenin activated the phosphorylation of p38 and p53 via increased c-Myc levels. In conclusion, our results indicate that apigenin induces apoptosis mediated via c-Myc with concomitant phosphorylation of p53 and p38 in FRO ATC cells. These findings suggest that augmented c-Myc acts as a core regulator and is necessary for apigenin-induced apoptosis in FRO ATC cells.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23376608     DOI: 10.1016/j.mce.2013.01.012

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  12 in total

1.  Akt inhibition enhances the cytotoxic effect of apigenin in combination with PLX4032 in anaplastic thyroid carcinoma cells harboring BRAFV600E.

Authors:  S H Kim; J G Kang; C S Kim; S H Ihm; M G Choi; H J Yoo; S J Lee
Journal:  J Endocrinol Invest       Date:  2013-09-27       Impact factor: 4.256

2.  Apigenin in combination with Akt inhibition significantly enhances thyrotropin-stimulated radioiodide accumulation in thyroid cells.

Authors:  Aparna Lakshmanan; Andrea I Doseff; Matthew D Ringel; Motoyasu Saji; Bernard Rousset; Xiaoli Zhang; Sissy M Jhiang
Journal:  Thyroid       Date:  2014-03-06       Impact factor: 6.568

3.  Plant flavone apigenin: An emerging anticancer agent.

Authors:  Eswar Shankar; Aditi Goel; Karishma Gupta; Sanjay Gupta
Journal:  Curr Pharmacol Rep       Date:  2017-10-14

4.  Suppression of NF-κB and NF-κB-Regulated Gene Expression by Apigenin through IκBα and IKK Pathway in TRAMP Mice.

Authors:  Sanjeev Shukla; Eswar Shankar; Pingfu Fu; Gregory T MacLennan; Sanjay Gupta
Journal:  PLoS One       Date:  2015-09-17       Impact factor: 3.240

5.  Screening of differentially expressed protein kinases in bone marrow endothelial cells and the protective effects of the p38a inhibitor SB203580 on bone marrow in liver fibrosis.

Authors:  Bo Gao; Wang Sun; Xianzhi Meng; Dongbo Xue; Weihui Zhang
Journal:  Mol Med Rep       Date:  2016-10-12       Impact factor: 2.952

Review 6.  Flavonoids, Thyroid Iodide Uptake and Thyroid Cancer-A Review.

Authors:  Carlos F L Gonçalves; Mariana L de Freitas; Andrea C F Ferreira
Journal:  Int J Mol Sci       Date:  2017-06-12       Impact factor: 5.923

7.  Association of microRNA-related gene XPO5 rs11077 polymorphism with susceptibility to thyroid cancer.

Authors:  Jing Wen; Qingjun Gao; Nanpeng Wang; Wei Zhang; Kun Cao; Qiang Zhang; Shi Chen; Lixin Shi
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

8.  Apigenin induces the apoptosis and regulates MAPK signaling pathways in mouse macrophage ANA-1 cells.

Authors:  Yuexia Liao; Weigan Shen; Guimei Kong; Houning Lv; Wenhua Tao; Ping Bo
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

9.  Apigenin inhibits the proliferation of adenoid cystic carcinoma via suppression of glucose transporter-1.

Authors:  Jin Fang; Yang-Yang Bao; Shui-Hong Zhou; Jun Fan
Journal:  Mol Med Rep       Date:  2015-08-20       Impact factor: 2.952

10.  Potential Role of DEC1 in Cervical Cancer Cells Involving Overexpression and Apoptosis.

Authors:  Fuyuki Sato; Ujjal K Bhawal; Nao Sugiyama; Shoko Osaki; Kosuke Oikawa; Yasuteru Muragaki
Journal:  Clocks Sleep       Date:  2020-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.